These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 15829323

  • 1. Tumour CEA as predictor of better outcome in squamous cell carcinoma of the lung.
    Veronesi G, Pelosi G, Sonzogni A, Leon ME, D'Aiuto M, Gasparri R, De Braud F, De Pas T, Sandri M, Spaggiari L.
    Lung Cancer; 2005 May; 48(2):233-40. PubMed ID: 15829323
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N.
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [Abstract] [Full Text] [Related]

  • 3. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N.
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [Abstract] [Full Text] [Related]

  • 4. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung.
    Fukai R, Sakao Y, Sakuraba M, Oh S, Shiomi K, Sonobe S, Saitoh Y, Miyamoto H.
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308
    [Abstract] [Full Text] [Related]

  • 5. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
    Sawabata N, Maeda H, Yokota S, Takeda S, Koma M, Tokunaga T, Ito M.
    Cancer; 2004 Aug 15; 101(4):803-9. PubMed ID: 15305413
    [Abstract] [Full Text] [Related]

  • 6. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
    Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S.
    Lung Cancer; 2007 Dec 15; 58(3):369-75. PubMed ID: 17697728
    [Abstract] [Full Text] [Related]

  • 7. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH, Huang CS, Hsu HS, Huang WJ, Lee HC, Huang BS, Huang MH.
    Ann Thorac Surg; 2007 Feb 15; 83(2):419-24. PubMed ID: 17257963
    [Abstract] [Full Text] [Related]

  • 8. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S, Kimura H, Iwai N, Shima M, Ando M, Kuriyama T.
    Anticancer Res; 2001 Feb 15; 21(4B):3085-92. PubMed ID: 11712815
    [Abstract] [Full Text] [Related]

  • 9. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Cataldo I, Sala M, Caldiera S, Bombardieri E.
    Anticancer Res; 1999 Feb 15; 19(4C):3613-8. PubMed ID: 10629660
    [Abstract] [Full Text] [Related]

  • 10. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
    Wang CY, Huang MS, Huang MH, Lee HC, Hsu HS.
    J Surg Res; 2010 Oct 15; 163(2):e45-50. PubMed ID: 20638687
    [Abstract] [Full Text] [Related]

  • 11. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
    Muley T, Dienemann H, Ebert W.
    Anticancer Res; 2003 Oct 15; 23(5b):4085-93. PubMed ID: 14666606
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
    Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, Mandai K, Eguchi K.
    Anticancer Res; 2000 Oct 15; 20(3B):2177-80. PubMed ID: 10928173
    [Abstract] [Full Text] [Related]

  • 13. Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
    Muley T, Fetz TH, Dienemann H, Hoffmann H, Herth FJ, Meister M, Ebert W.
    Lung Cancer; 2008 Jun 15; 60(3):408-15. PubMed ID: 18083270
    [Abstract] [Full Text] [Related]

  • 14. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
    Slodkowska J, Szturmowicz M, Rudzinski P, Giedronowicz D, Sakowicz A, Androsiuk W, Zakrzewska-Rowinska E.
    Eur J Cancer Prev; 1998 Feb 15; 7(1):51-60. PubMed ID: 9511851
    [Abstract] [Full Text] [Related]

  • 15. CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients.
    Muley T, Dienemann H, Ebert W.
    Anticancer Res; 2004 Feb 15; 24(3b):1953-6. PubMed ID: 15274383
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL, Diez M, Torres A, Maestro M, Ortega D, Hernando F, Gómez A, Garcia-Asenjo J, Balibrea JL.
    Cancer; 1996 Mar 15; 77(6):1066-72. PubMed ID: 8635125
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
    Tomita M, Matsuzaki Y, Edagawa M, Shimizu T, Hara M, Onitsuka T.
    Ann Thorac Cardiovasc Surg; 2004 Apr 15; 10(2):76-80. PubMed ID: 15209547
    [Abstract] [Full Text] [Related]

  • 18. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F, Aydiner A, Topuz E, Yasasever V, Karadeniz A, Saip P.
    J Exp Clin Cancer Res; 2000 Dec 15; 19(4):477-81. PubMed ID: 11277326
    [Abstract] [Full Text] [Related]

  • 19. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
    Graziano SL, Tatum AH, Newman NB, Oler A, Kohman LJ, Veit LJ, Gamble GP, Coleman MJ, Barmada S, O'Lear S.
    Cancer Res; 1994 Jun 01; 54(11):2908-13. PubMed ID: 8187076
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer.
    Nisman B, Amir G, Lafair J, Heching N, Lyass O, Peretz T, Barak V.
    Anticancer Res; 1999 Jun 01; 19(4C):3549-52. PubMed ID: 10629651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.